No, Concerta 54 mg tablets should NOT be cut in half.
Concerta tablets must be swallowed whole and should not be chewed, divided, or crushed 1. This is explicitly stated in the FDA-approved drug labeling and patient counseling information.
Why Concerta Cannot Be Split
Concerta uses a specialized OROS (Osmotic-Release Oral System) delivery mechanism 2. The tablet contains a nonabsorbable shell designed to release methylphenidate at a controlled rate over 12 hours through an osmotic pump system 3. The medication is released through a laser-drilled hole in the tablet as water enters the shell.
Cutting or crushing the tablet destroys this delivery system, which would:
- Release the entire dose immediately instead of gradually over 12 hours
- Eliminate the extended-release properties that make once-daily dosing possible
- Potentially cause overdose from rapid drug release
- Result in loss of symptom control later in the day
Clinical Evidence
The FDA labeling explicitly instructs: "Tablets should not be chewed, divided, or crushed. The medication is contained within a nonabsorbable shell designed to release the drug at a controlled rate" 1.
Guidelines specifically note that Concerta is "resistant to diversion (cannot be ground up or snorted)" 2, highlighting that the formulation is intentionally designed to prevent alteration.
While older research on immediate-release and standard sustained-release methylphenidate showed that splitting might be "clinically acceptable" 4, this does NOT apply to OROS formulations like Concerta. The OROS technology is fundamentally different from older sustained-release preparations.
What To Do Instead
If dose adjustment is needed:
- Use the available tablet strengths: Concerta comes in 18 mg, 27 mg, 36 mg, and 54 mg tablets 1
- Switch to immediate-release methylphenidate if smaller dose increments are required 2
- Consider alternative formulations that allow for more flexible dosing (e.g., capsules that can be opened and sprinkled on food, though not Concerta)
Critical Safety Point
Splitting sustained-release preparations is inappropriate and potentially dangerous due to "alteration of the rate of drug release" 5. This can lead to:
- Acute overdose symptoms (cardiovascular effects, psychiatric symptoms)
- Loss of therapeutic effect during the intended duration of action
- Increased risk of abuse potential from immediate drug release